These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21443344)

  • 41. Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression.
    Bangen KJ; Delano-Wood L; Wierenga CE; McCauley A; Jeste DV; Salmon DP; Bondi MW
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):175-82. PubMed ID: 19551707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Taub ES
    Neuropsychology; 2011 Nov; 25(6):679-89. PubMed ID: 21728427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.
    Whitson HE; Potter GG; Feld JA; Plassman BL; Reynolds K; Sloane R; Welsh-Bohmer KA
    J Alzheimers Dis; 2018; 64(4):1137-1148. PubMed ID: 30010120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
    Mayeux R; Small SA; Tang M; Tycko B; Stern Y
    Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Worry Level on Recall Memory for Odors in ApoE-ε4 Carriers and Non-Carriers.
    Bower ES; Szajer J; Murphy C
    J Int Neuropsychol Soc; 2019 May; 25(5):546-556. PubMed ID: 30987686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status.
    Xing Y; Tang Y; Jia J
    Behav Neurol; 2015; 2015():275256. PubMed ID: 26538817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
    Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
    Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
    El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
    Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
    Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
    Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
    Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.